The pharmaceu(cal industry is facing a lot of challenges recently, like demographic changes, the difficulty of introducing new products to the market, new diseases complexity, the decreased R&D efficiency, the growth of the demands of the regulatory authori(es, and of course, the loss of the blockbuster's patent during the coming years. For all this reasons, this Master's Thesis will explain the common trends for all the pharmaceu(cal companies in the United States, like the personalized medicine therapies, the focused expansion into emerging markets, the new growth models based in merges and acquisi(ons, the increasing cost of the health services over the country's GDP growth, some different ways to promote pharmaceu(cal products, new rela(onships between the pharmaceu(cal industry and pa(ents, providers and and government, the pressure to carry out an efficient alloca(on of resources to reduce costs, and the diversifica(on of the porZolio. To provide a comprehensive view of all the aspects involved in the defini(on of these trends, the project structure is as follows: I. Principal Facts of Health Care in the US II. The Health Care in the US III. The Pharmaceu)cal Industry in the US IV. Conclusions. Pharmaceu)cal Market Trends in the US

Outgoing